Irene Reijers

5PUBLICATIONS
78CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 30, 2025
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors.

Kristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem

|Sep 05, 2023
Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma.

Lotte L Hoeijmakers, Irene L M Reijers, Christian U Blank

|Apr 24, 2023
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence.

Esmee P Hoefsmit, Franziska Völlmy, Elisa A Rozeman

|Mar 15, 2023
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma.

Irene L M Reijers, Disha Rao, Judith M Versluis

|Feb 08, 2023
Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells.

Esmée P Hoefsmit, Paula T van Royen, Disha Rao

Pageof 1